The immunologic basis of COVID-19: a clinical approach

authors:

avatar Samira Rajaei ORCID 1 , * , avatar Ali Dabbagh ORCID 2

MD, PhD, Associate Professor, Immunology Department, School of Medicine, Tehran University of Medical Sciences, Tehran
MD, Professor of Cardiac Anesthesia,Anesthesiology Research Center, ShahidBeheshti University of Medical Sciences, Tehran, Iran

how to cite: Rajaei S, Dabbagh A. The immunologic basis of COVID-19: a clinical approach. J Cell Mol Anesth. 2020;5(1):e149609. https://doi.org/10.22037/jcma.v5i1.29778.

Abstract

The novel Severe Acute Respiratory Disease Corona Virus (SARS-CoV2) has leaded to a global infection and a pandemic afterwards. This pandemic is one of the greatest global challenges for the health system.In this review, the immunologic basis of the human body response after infection with SARS-CoV2 has been reviewed with discussions on both innate and adaptive immunity. Due to the relatively short time after appearance of the problem, the currently available evidence exclusively dealing with SARS-CoV2 and the SARS-CoV2 disease (COVID-19) are scant; especially in the field of cellular and molecular medicine; however, previous studies especially focusing on SARS-CoV and MERS are available. A full review on these topics is presented here.At the final part of the manuscript, involvement of the main human organs with COVID-19 is briefed.